Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy.

Reid, D M

Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy. [electronic resource] - Calcified tissue international Oct 2001 - 242-7 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

0171-967X

10.1007/s00223-001-1060-8 doi


Adolescent
Adult
Aged
Aged, 80 and over
Bone Density--drug effects
Bone and Bones--drug effects
Calcium Channel Blockers--therapeutic use
Dose-Response Relationship, Drug
Double-Blind Method
Etidronic Acid--analogs & derivatives
Humans
Male
Middle Aged
Osteoporosis--chemically induced
Prednisone--adverse effects
Risedronic Acid
Spinal Fractures--chemically induced
Treatment Outcome